Table 5

Outcomes following SAVR in the current study (UK AVR) and those in other national registries and recent trials comparing SAVR with TAVI

OutcomeUK SAVRThourani et al15Tokuda et al16Partner 2A22Partner 36Evolut7PIVOTAL5NOTION18
SAVR N=31 277SAVR
N=141 905
SAVR
N=20 514
SAVR
N=1021
TAVI N=1011SAVR N=454TAVI N=496SAVR N=678TAVI N=725SAVR N=357TAVI N=390SAVR N=135TAVI N=145
In-hospital death/30-day mortality (%)1.92.5NR8.06.11.10.41.30.54.53.33.72.1
Stroke (%)1.1NR1.66.15.52.40.63.43.46.24.93.01.4
Reoperation for bleeding* (%)3.63.93NRNRNRNRNRNRNRNRNRNR
Post procedure bleeding* (%)NR43.410.411.91.27.52.469.541.711.320.9
Deep sternal wound infection (%)0.140.31.1NRNRNRNRNR
Length of hospital stay (days)77.9±7.2NRNR7.03.0NRNRNRNR8.9±6.212.9±11.6
New pacemaker implantation (%)1.6NRNR6.98.4.06.56.117.47.119.81.634.1
  • *Reoperation for bleeding and postoperative bleeding were major and required intervention.

  • AVR, aortic valve replacement; NR, not reported; SAVR, surgical aortic valve replacement; TAVI, transcatheter aortic valve implantation.